Serological analysis of human tumor antigens: molecular definition and implications.
about
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.Serological detection of cutaneous T-cell lymphoma-associated antigensIdentification of a meiosis-specific protein as a member of the class of cancer/testis antigensSerological identification and expression analysis of gastric cancer-associated genesHuman carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancersCancer/testis antigens and gametogenesis: a review and "brain-storming" sessionGastric cancer: prevention, screening and early diagnosisEvaluation of current cancer immunotherapy: hemato-oncologySEREX identification of new tumour-associated antigens in cutaneous T-cell lymphomaIdentification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries.PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme.Identification of selectively expressed genes and antigens in CTCL.Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities.Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.Evidence for a bias toward intracellular antigens in the local humoral anti-tumor immune response of a colorectal cancer patient revealed by phage display.Expression of cancer/testis antigens in cutaneous T cell lymphomas.Molecular characterization of virus-induced autoantibody responses.Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy.CD40 stimulation accelerates deletion of tumor-specific CD8(+) T cells in the absence of tumor-antigen vaccination.Immunologic approaches to antigen discovery for cancer vaccines.A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing.Tumor-associated autoantibody signature for the early detection of gastric cancer.Over-expression of the testis-specific gene TSGA10 in cancers and its immunogenicity.Immunotherapy of melanoma.Cancer genetics and tumor antigens: time for a combined view?Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen.Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas.Towards patient-specific tumor antigen selection for vaccination.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display.Intratumoral immunotherapy: using the tumour against itself.Mining gut microbiome oligopeptides by functional metaproteome display.A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.Tumor-associated antigen arrays for the serological diagnosis of cancer.Antibody profiling with protein antigen microarrays in early stage cancer.Immunology and immunotherapy approaches for prostate cancer.The adaptive immune response to sporadic cancer.
P2860
Q24535835-8E46DE79-A469-4ABE-8D37-B2E0F2FFE455Q24544114-006BDBA7-375F-41FB-B4A3-6C49D1E5A61CQ24569553-82C0F611-2010-4CDD-9C8A-FCA69506F3B0Q24642763-2F3EC773-A040-4BD3-908C-F31B8E38689DQ24651144-61E4C1E9-58E1-4563-AC28-C2C7829295A6Q24798047-F7873D11-B429-4429-8437-FF1B9A6A9D3CQ26860418-D5934F80-F7AB-4E6E-AE83-BA3182EA6E10Q27006179-142FEE6C-013B-4A36-B676-94AA03ED6D5AQ28247977-0A86AD6E-F1C6-4137-B20F-F804FAE4CA3FQ30442906-88A785C0-C60C-429E-BE62-FDBF8C49DEF6Q30657549-753D511E-9ED1-4B7F-8544-D50227C16A09Q30690737-E5A2FD57-8588-465F-9734-6DE4A5BA310AQ30835465-5471BAB3-2B4F-4772-9BD4-BD4B221321DCQ30863574-39980D80-366E-4788-8501-89AC3DB0F4F1Q30969714-90ADDAEA-3016-48F5-9046-DC0C333301EDQ31004523-E2190B2C-78C3-4680-A084-96E8BA48658AQ31036179-1953FAA7-F214-42C0-B2ED-343FBE8CF0F9Q31110185-D0788F2D-7F04-49DE-8982-DC8B0BF496F5Q31111353-416CB385-044B-49BB-BEE1-2C061871868EQ33943864-FBA0C56A-261B-43CB-B6E3-4DDAE6FA81E6Q34074742-C0311043-7F66-4BF6-A626-8A17C9A6EB94Q34130453-352A407F-531A-4E39-90BA-FA5396881FF7Q34299043-34015808-DB2F-4CDE-8230-386FB8C30B05Q34316228-ABAE0446-E3E9-44DE-B56E-56CCCD847DD6Q34383950-D87E9FA4-5F28-4A4F-BC44-2A47C4262DA9Q34495646-73A914F5-928D-46C6-93FA-9681B1D1CC96Q34721861-A45560CD-DEF5-4E7F-A506-1BDCACC1EE05Q34912810-969042B4-ED4E-4FEE-9793-E8C317CAE337Q35005960-6B0346CE-940F-410D-A018-AA4F945C61EAQ35110486-0739FD93-B1D7-40D7-930A-231D00479A79Q35160569-E76DE36E-DA4C-453F-9A1A-DB74E1B6F480Q35918309-8195D011-4C9A-40EE-B594-B5DC891EEB0CQ35988030-C81E089A-411F-4844-AC55-7A603FCBFFEDQ36153085-D5F002B6-8E80-49A0-A3FE-34F9A160FF55Q36400634-B5C77547-4609-45AE-A56C-45D38FFA90F0Q36471831-E6D4AB33-0929-4AC1-8CBF-767090499B78Q36491988-454A5F05-4989-4D82-8EB8-823DC24B8F8EQ36682206-8DB7B782-6E00-49A3-9FE6-AEA36F2DD0E6Q36786512-EA37993D-7C5B-44EB-8A27-6DC4EB0260C7Q36990593-9E5458F4-CCFB-47D6-B538-D8C9BC7141A0
P2860
Serological analysis of human tumor antigens: molecular definition and implications.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Serological analysis of human tumor antigens: molecular definition and implications.
@en
type
label
Serological analysis of human tumor antigens: molecular definition and implications.
@en
prefLabel
Serological analysis of human tumor antigens: molecular definition and implications.
@en
P1476
Serological analysis of human tumor antigens: molecular definition and implications.
@en
P2093
Pfreundschuh M
P304
P356
10.1016/S1357-4310(97)01081-2
P50
P577
1997-08-01T00:00:00Z